SE7904316L - Reducerande komposition for teknetium-99m samt forfarande for framstellning av med teknetium-99m merkta ligander - Google Patents

Reducerande komposition for teknetium-99m samt forfarande for framstellning av med teknetium-99m merkta ligander

Info

Publication number
SE7904316L
SE7904316L SE7904316A SE7904316A SE7904316L SE 7904316 L SE7904316 L SE 7904316L SE 7904316 A SE7904316 A SE 7904316A SE 7904316 A SE7904316 A SE 7904316A SE 7904316 L SE7904316 L SE 7904316L
Authority
SE
Sweden
Prior art keywords
teknetium
technetium
ligands
reducing
preparing
Prior art date
Application number
SE7904316A
Other languages
English (en)
Swedish (sv)
Inventor
L L Camin
M P Liteplo
Original Assignee
New England Nuclear Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Nuclear Corp filed Critical New England Nuclear Corp
Publication of SE7904316L publication Critical patent/SE7904316L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G99/00Subject matter not provided for in other groups of this subclass
    • C01G99/006Compounds containing, besides a metal not provided for elsewhere in this subclass, two or more other elements other than oxygen or hydrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE7904316A 1978-05-25 1979-05-16 Reducerande komposition for teknetium-99m samt forfarande for framstellning av med teknetium-99m merkta ligander SE7904316L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/909,385 US4272503A (en) 1978-05-25 1978-05-25 Reductant composition for technetium-99m and method for making technetium-99m labelled ligands

Publications (1)

Publication Number Publication Date
SE7904316L true SE7904316L (sv) 1979-11-26

Family

ID=25427158

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7904316A SE7904316L (sv) 1978-05-25 1979-05-16 Reducerande komposition for teknetium-99m samt forfarande for framstellning av med teknetium-99m merkta ligander

Country Status (10)

Country Link
US (1) US4272503A (nl)
JP (2) JPS54160305A (nl)
BE (1) BE876562A (nl)
CA (1) CA1111765A (nl)
CH (1) CH649924A5 (nl)
DE (1) DE2920770A1 (nl)
FR (1) FR2430236A1 (nl)
GB (1) GB2023327B (nl)
NL (1) NL7904059A (nl)
SE (1) SE7904316L (nl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same
US4406876A (en) * 1980-10-14 1983-09-27 Research Foundation Of The State Univ. Of New York Sulfur free small-particle production of technetium sulfur colloid
ES8404857A1 (es) * 1981-10-27 1984-05-16 Hybritech Inc Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor.
DE3237573A1 (de) * 1982-10-09 1984-04-12 Hoechst Ag, 6230 Frankfurt Technetium-99m-tri- und tetraphosphonate zur szintigraphischen dastellung res-haltiger organe und der lymphgefaesse und verfahren zu deren herstellung
US4574079A (en) * 1983-05-27 1986-03-04 Gavras Haralambos P Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites
EP0163701A1 (en) * 1983-12-06 1985-12-11 The Royal Melbourne Hospital PREPARATION OF RADIOPHARMACEUTICALS BASED ON TECHNETIUM-99m/
USRE38435E1 (en) * 1983-12-28 2004-02-24 Daicel Chemical Industries, Ltd. Separating agent
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
US5164175A (en) * 1986-12-10 1992-11-17 Hoechst Aktiengesellschaft Diagnostic aid containing an organ-specific substance labeled with technetium-99m
US5059541A (en) * 1988-04-29 1991-10-22 Neorx Corporation Minimal derivatization of proteins
US5208007A (en) * 1988-11-22 1993-05-04 Board Of Regents Of The University Of Oklahoma Isotopic tracer composition and method for making and using same
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
CA2158249A1 (en) * 1993-03-31 1994-10-13 James W. Brodack Radiopharmaceutical formulations having non-stannous reductants
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
CA2175557A1 (en) * 1993-11-16 1995-05-26 Alfred Pollak Immobilized labelling method
US5774782A (en) * 1996-05-22 1998-06-30 Lockheed Martin Energy Systems, Inc. Technetium-99m generator system
US6783672B2 (en) 2001-01-18 2004-08-31 Kemmons A. Tubbs Integrated high throughput system for the mass spectrometry of biomolecules
US7799526B2 (en) * 2002-11-21 2010-09-21 The University Of North Carolina At Chapel Hill Phosphoprotein detection reagent and methods of making and using the same
GB0804406D0 (en) * 2008-03-10 2008-04-16 Univ Zuerich Metal complexes
US20120298929A1 (en) * 2010-02-05 2012-11-29 Noritsuka Mizumura Reducing agent composition for the conductive metal paste

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784453A (en) * 1970-12-16 1974-01-08 H Dworkin Process and apparatus for making radioactive labeled protein material
DE2166643A1 (de) * 1971-03-25 1975-01-30 Minnesota Mining & Mfg Verfahren zum radioaktiven kennzeichnen von pharmazeutisch unbedenklichen mikropartikeln
DE2127809A1 (en) * 1971-06-01 1972-12-14 Kort, Waiter, Dr , 1000 Berlin Radioactive technetium-iron complex - for scintigraphy of organs and blood vessels
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
US3873680A (en) * 1972-08-30 1975-03-25 Minnesota Mining & Mfg Mercaptan and thioketal complexes of technetium 99M for diagnostic scanning
US3868383A (en) * 1973-04-23 1975-02-25 Lilly Co Eli Process for preparing 5-({60 -cyanobenzylidene) oxazolidine-2, 4-diones
CA1070695A (en) * 1975-09-02 1980-01-29 Michael D. Loberg Iminodiacetic acid pharmaceutical
DE2543351A1 (de) * 1975-09-29 1977-04-07 Henkel & Cie Gmbh Praeparate zur herstellung von 99m technetum-radiodiagnostika

Also Published As

Publication number Publication date
FR2430236A1 (fr) 1980-02-01
GB2023327B (en) 1982-08-25
FR2430236B1 (nl) 1983-05-13
CA1111765A (en) 1981-11-03
BE876562A (fr) 1979-11-26
GB2023327A (en) 1979-12-28
CH649924A5 (de) 1985-06-28
JPS58146514A (ja) 1983-09-01
NL7904059A (nl) 1979-11-27
JPS54160305A (en) 1979-12-19
US4272503A (en) 1981-06-09
DE2920770A1 (de) 1979-11-29

Similar Documents

Publication Publication Date Title
SE7904316L (sv) Reducerande komposition for teknetium-99m samt forfarande for framstellning av med teknetium-99m merkta ligander
NZ222677A (en) Pharmaceutical compositions and diagnostic agents comprising metal chelate complexes and additional metal complexing agent and/or weak metal chelate to enhance tolerance
DE3277067D1 (en) Detergent compounds and compositions
SE7604770L (sv) Pulveriserad herdbar komposition och sett for dess framstellning
SE415782B (sv) Slithallfast kompositlegering omfattande sferoidala partiklar
ATE74766T1 (de) Verfahren zur herstellung von antikoerperzusammensetzungen von therapeutischen mitteln mit verlaengerter serumhalbwertzeit.
JPS5573662A (en) Novel hydroxyethyllazole compound*its manufacture and its use as medicine
DK395484A (da) Bisamid-bisthiolforbindelser samt radiofarmaceutiske praeparater indeholdende disse
BE833864A (fr) Derives de l'amino-3 pyridine et compositions tinctoriales les contenant
FR2336485A1 (fr) Compositions d'atmospheres et procedes pour utiliser celles-ci pour les traitements de surface de metaux ferreux
GB1540292A (en) Additive concentrates and lubricating compositions containing these concentrates
FR2325359A1 (fr) Compositions pour l'etablissement de diagnostics radiologiques au technetium 99m
NL176748B (nl) Werkwijze voor het bereiden van een verbinding van tweewaardig tin bevattend preparaat, geschikt voor de bereiding van op technetium-99m gebaseerde, radiografische schermbeeldvormende middelen, alsmede kits, bevattende een dergelijk preparaat.
GB2061987B (en) Cyclodextrin complexes their preparation and pharmaceutical compositions containing them
IT1119944B (it) Complessi di inclusione di ciclo destrina camomilla procedimento per la loro preparazione e composizioni che li contengono
IT7824545A0 (it) Composizione detergente granulare o in polvere di elevata fluidita'.
BE846625A (fr) Compositions pour l'etablissement des diagnostics radiologiques au technetium 99m
DE2861560D1 (en) Complexes of bivalent copper, methods of preparation thereof and compositions containing said complexes
DE3063449D1 (en) Complexes of bivalent copper, methods of preparation thereof and compositions containing said complexes
FR2302346A1 (fr) Composition d'alliage destinee au soudage de pieces
ES375358A1 (es) Un procedimiento para preparar un coloide de azufre y tec- necio 99m.
DE2961347D1 (de) Mischmetal-nickel-aluminium alloys
IT1065824B (it) Complessi cromiferi asimmetrici 1:2 loro preparazione e loro applicazione come coloranti
IL35749A (en) Stabilized iron chelate compositions and plant treating agents containing them
IL48189A (en) Substituted iminodiacetic acids,process for their preparation,chelating agents containing said substituted iminodiacetic acids and pharmaceutical compositions for treatment of renal calcule containing them

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7904316-2

Effective date: 19860926

Format of ref document f/p: F